Mexico Diabetes Drugs and Devices Market Share

Statistics for the 2023 & 2024 Mexico Diabetes Drugs and Devices market share, created by Mordor Intelligence™ Industry Reports. Mexico Diabetes Drugs and Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Mexico Diabetes Drugs and Devices Industry

The manufacturers of insulin delivery devices are spending a huge amount on the R&D of the devices. For example, Novo Nordisk partnered with Abbott Diabetes Care, which may also assist to enable insulin statistics to be shared between Novo Nordisk-connected insulin pens and digital fitness equipment well suited to the FreeStyle Libre portfolio of products.

Mexico Diabetes Drugs and Devices Market Leaders

  1. Medtronics

  2. Roche

  3. Sanofi

  4. NovoNordisk

  5. Omnipod

*Disclaimer: Major Players sorted in no particular order

Mexico Diabetes Drugs and Devices Market Concentration

Mexico Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)